Jakob Schöllhammer Knudsen

8PUBLICATIONS
18CO-AUTHORS
Major global burdens of diseaseDental therapeutics, pharmacology and toxicologyPharmacogenomicsPredictive and prognostic markersBiologically active molecules
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Jul 19, 2021
Hospitalization for hypoglycaemia in people with diabetes in Denmark, 1997-2017: Time trends in incidence and HbA1c and glucose-lowering drug use before and after hypoglycaemia.

Mads Bisgaard Bengtsen, Jakob Schöllhammer Knudsen, Maria Bisgaard Bengtsen

|Jun 30, 2021
A large remaining potential in lipid-lowering drug treatment in the type 2 diabetes population: A Danish nationwide cohort study.

Hanan Amadid, Pernille F Rønn, Maria Bekker-Nielsen Dunbar

|Nov 03, 2020
Real-world use of cardioprotective glucose-lowering drugs in patients with type 2 diabetes and cardiovascular disease: A Danish nationwide cohort study, 2012 to 2019.

Kristian L Funck, Jakob S Knudsen, Troels K Hansen

|Mar 05, 2020
Changes in SGLT2i and GLP-1RA real-world initiator profiles following cardiovascular outcome trials: A Danish nationwide population-based study.

Jakob S Knudsen, Lisbeth M Baggesen, Maria Lajer

|Mar 21, 2019
Clinical characteristics and glucose-lowering drug utilization among patients initiating liraglutide in Denmark: a routine clinical care prescription study.

Jakob S Knudsen, Reimar W Thomsen, Anton Pottegård

|May 27, 2017
Novel selective PDE type 1 inhibitors cause vasodilatation and lower blood pressure in rats.

Morten Laursen, Lilliana Beck, Jan Kehler

Pageof 2

Frequent Collaborators

5 joint publications

Reimar Wernich Thomsen

1 joint publications

Kristian L Funck

1 joint publications

Troels K Hansen

1 joint publications

Erik L Grove